Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Sep 30, 2022--
The "Reiter's Syndrome Treatment Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027 Segmented By Drug Type, Immunosuppressive Drugs, Others, By Dosage Form, By Route of Administration, By Distribution Channel, By End User, By Region" report has been added to ResearchAndMarkets.com's offering.
The global Reiter's syndrome treatment market is anticipated to grow at a significant CAGR during the forecast period, 2023-2027. The market growth can be attributed to the rising instances of reactive arthritis and advancements in treatment processes and methods.
Besides, advances in the healthcare industry have led to better accessibility of patient care suffering from severe conditions like reactive arthritis, contributing to the growth of the global Reiter's syndrome treatment market.
Reiter's syndrome is a type of inflammatory arthritis, which is also known as reactive arthritis. The painful inflammation is caused by a bacterial infection. These bacteria are frequently found in the genital tract, such as Chlamydia trachomatis, or the bowel, such as Campylobacter, Salmonella, Shigella, and Yersinia. Genital bacteria spread through sex and usually causes no noticeable symptoms. A pus-like or watery discharge from the genitals is observed in some cases. Bowel bacteria, on the other hand, usually cause diarrhea along with discharge and can be considered minor symptom of Reiter's syndrome.
Rapidly increasing reactive arthritis incidences and rising demand for effective treatment are expected to drive the global Reiter's syndrome treatment market over the next five years. When compared to other types of arthritis, reactive arthritis is a rare form. As of 2021, more than 350 million arthritis patients are affected by Reiter's syndrome. According to the CDC, arthritis affects 24% of all adults in the United States, approx. 58.5 million people. One in every four adults has arthritis and suffers from severe joint pain.
Reiter's syndrome affects approximately 27 per 100,000 people worldwide, with adult males aged 20 to 40 most affected. Growing population, rising instances of unprotected sexual intercourse increase the population's chances of contracting the disease and assist in the growth of the global Reiter's syndrome treatment market over the next five years.
Years considered for this report:
Objective of the Study:
Companies Mentioned
Report Scope:
In this report, global Reiter's syndrome treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Reiter's Syndrome Treatment Market, By Drug Type:
Reiter's Syndrome Treatment Market, By Dosage Form:
Reiter's Syndrome Treatment Market, By Route of Administration:
Reiter's Syndrome Treatment Market, By Distribution Channel:
Reiter's Syndrome Treatment Market, By End User:
Reiter's Syndrome Treatment Market, By Region:
For more information about this report visit https://www.researchandmarkets.com/r/50fi2l
View source version on businesswire.com:https://www.businesswire.com/news/home/20220930005429/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH GENERAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 09/30/2022 10:40 AM/DISC: 09/30/2022 10:41 AM
http://www.businesswire.com/news/home/20220930005429/en